JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.02B |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$3.55B |
| 3 |
Eli Lilly
LLY
|
+$2.61B |
| 4 |
Amphenol
APH
|
+$2.33B |
| 5 |
TotalEnergies
TTE
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$9.67B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$7.48B |
| 3 |
Meta Platforms (Facebook)
META
|
+$7.25B |
| 4 |
NVIDIA
NVDA
|
+$6.05B |
| 5 |
Microsoft
MSFT
|
+$5.54B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Miscellaneous | 24.97% |
| 3 | Financials | 9.75% |
| 4 | Consumer Discretionary | 8.78% |
| 5 | Healthcare | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3151
FT Vest Fund of Buffer ETFs
BUFR
$10.8B
| $5.28M | ﹤0.01% |
154,002
+3,107
| +2% | +$105K |
2022 Q4
12 quarters
|
|
3152
PUT
Prologis
PLD
$123B
| $5.27M | ﹤0.01% |
41,300
+40,000
| +3,077% | +$4.99M |
2024 Q2
6 quarters
|
|
3153
CALL
EQT Corp
EQT
$31.4B
| $5.27M | ﹤0.01% |
98,300
-145,700
| -60% | -$8.19M |
2020 Q3
21 quarters
|
|
3154
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.16B
| $5.26M | ﹤0.01% |
217,067
-101,373
| -32% | -$2.46M |
2020 Q1
23 quarters
|
|
3155
Myers Industries
MYE
$1.19B
| $5.24M | ﹤0.01% |
279,823
-63,222
| -18% | -$1.12M |
2013 Q2
50 quarters
|
|
3156
Navigator Holdings
NVGS
$1.47B
| $5.23M | ﹤0.01% |
302,165
+91,368
| +43% | +$1.53M |
2025 Q1
3 quarters
|
|
|
OS
3157
DELISTED
OneStream Inc
OS
| $5.23M | ﹤0.01% |
284,661
+174,818
| +159% | +$3.33M |
2024 Q3
5 quarters
|
|
3158
Recursion Pharmaceuticals
RXRX
$2.21B
| $5.23M | ﹤0.01% |
1,278,944
+859,326
| +205% | +$4.26M |
2021 Q2
18 quarters
|
|
|
DMC
3159
Del Monte Corp
DMC
$1.4B
| $5.23M | ﹤0.01% |
146,801
-116,944
| -44% | -$4.17M |
2013 Q2
50 quarters
|
|
3160
Enovix
ENVX
$614M
| $5.23M | ﹤0.01% |
715,208
+532,821
| +292% | +$5.16M |
2021 Q4
16 quarters
|
|
3161
PUT
DexCom
DXCM
$32.2B
| $5.22M | ﹤0.01% |
78,700
+52,900
| +205% | +$3.42M |
2025 Q2
2 quarters
|
|
|
ECO
3162
Okeanis Eco Tankers
ECO
$3.41B
| $5.22M | ﹤0.01% |
+154,325
| New | +$5.23M |
2025 Q4
0 quarters
|
|
3163
Robert Half
RHI
$3.7B
| $5.22M | ﹤0.01% |
192,079
+30,337
| +19% | +$866K |
2013 Q2
50 quarters
|
|
3164
Artivion
AORT
$1.09B
| $5.22M | ﹤0.01% |
114,363
-7,836
| -6% | -$349K |
2016 Q2
38 quarters
|
|
3165
NovoCure
NVCR
$1.74B
| $5.21M | ﹤0.01% |
402,882
+120,698
| +43% | +$1.55M |
2017 Q4
32 quarters
|
|
3166
Columbia Multi-Sector Municipal Income ETF
MUST
$528M
| $5.2M | ﹤0.01% |
252,430
+142,445
| +130% | +$2.94M |
2023 Q4
8 quarters
|
|
3167
Northwest Bancshares
NWBI
$2.22B
| $5.2M | ﹤0.01% |
433,235
+4,803
| +1% | +$58.4K |
2015 Q4
40 quarters
|
|
3168
1st Source
SRCE
$2.09B
| $5.19M | ﹤0.01% |
83,112
+4,686
| +6% | +$290K |
2013 Q2
50 quarters
|
|
3169
Carriage Services
CSV
$511M
| $5.19M | ﹤0.01% |
122,780
+1,507
| +1% | +$65.4K |
2015 Q4
40 quarters
|
|
3170
Zai Lab
ZLAB
$2.73B
| $5.18M | ﹤0.01% |
293,703
+284,296
| +3,022% | +$6.66M |
2020 Q1
23 quarters
|
|
3171
Rocket Pharmaceuticals
RCKT
$281M
| $5.18M | ﹤0.01% |
1,475,624
-621,409
| -30% | -$2.13M |
2018 Q2
30 quarters
|
|
3172
Origin Bancorp
OBK
$1.65B
| $5.16M | ﹤0.01% |
137,262
-48,679
| -26% | -$1.74M |
2018 Q2
30 quarters
|
|
3173
Tidewater
TDW
$4.1B
| $5.15M | ﹤0.01% |
102,007
-85,243
| -46% | -$4.5M |
2013 Q2
50 quarters
|
|
3174
iShares MSCI USA Equal Weighted ETF
EUSA
$1.89B
| $5.14M | ﹤0.01% |
49,696
-489,653
| -91% | -$50.4M |
2022 Q4
12 quarters
|
|
3175
WD-40
WDFC
$2.72B
| $5.13M | ﹤0.01% |
26,055
-15,045
| -37% | -$2.97M |
2013 Q2
50 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2025 Portfolio in Review
As of Q4 2025, JP Morgan Chase held 7,944 positions worth $1.59T, down 4.6% from $1.67T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
JP Morgan Chase withdrew a net $106B in Q4 2025, closing 563 positions and reducing 3,329 holdings. Its most notable exit was Interpublic Group of Companies, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, JP Morgan Chase opened a new position in Quadratic Interest Rate Volatility and Inflation Hedge ETF worth $99.9M.
- JP Morgan Chase's largest Q4 2025 buy was Quadratic Interest Rate Volatility and Inflation Hedge ETF: 5,216,227 shares worth $99.9M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q4 2025, an estimated $4.02B increase.
- JP Morgan Chase's biggest Q4 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $9.67B.
- JP Morgan Chase fully exited Interpublic Group of Companies in Q4 2025, selling an estimated $228M.
- JP Morgan Chase's ten largest holdings make up 26% of its $1.59T portfolio in Q4 2025.
- JP Morgan Chase opened 577 new positions and closed 563 in Q4 2025.
- JP Morgan Chase's portfolio value fell 4.6% quarter-over-quarter to $1.59T.
Based on JP Morgan Chase's 13F filing for Q4 2025, filed 11 Feb 2026.